Ikarian Capital’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2K | Hold |
40,270
| – | – | ﹤0.01% | 102 |
|
|
2025
Q1 | $10.9K | Hold |
40,270
| – | – | ﹤0.01% | 116 |
|
|
2024
Q4 | $20.9K | Sell |
40,270
-99
| -0.2% | -$51 | ﹤0.01% | 115 |
|
|
2024
Q3 | $131K | Hold |
40,369
| – | – | 0.02% | 92 |
|
|
2024
Q2 | $121K | Hold |
40,369
| – | – | 0.02% | 81 |
|
|
2024
Q1 | $188K | Hold |
40,369
| – | – | 0.02% | 73 |
|
|
2023
Q4 | $167K | Hold |
40,369
| – | – | 0.02% | 70 |
|
|
2023
Q3 | $121K | Sell |
40,369
-25,122
| -38% | -$75.4K | 0.01% | 70 |
|
|
2023
Q2 | $161K | Hold |
65,491
| – | – | 0.03% | 73 |
|
|
2023
Q1 | $148K | Hold |
65,491
| – | – | 0.03% | 81 |
|
|
2022
Q4 | $229K | Buy |
+65,491
| New | +$229K | 0.06% | 55 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 113 |
|
|
2022
Q2 | – | Sell |
-21,801
| Closed | -$588K | – | 152 |
|
|
2022
Q1 | $588K | Buy |
21,801
+1,058
| +5% | +$28.5K | 0.08% | 87 |
|
|
2021
Q4 | $467K | Hold |
20,743
| – | – | 0.07% | 100 |
|
|
2021
Q3 | $544K | Sell |
20,743
-279,464
| -93% | -$7.33M | 0.04% | 119 |
|
|
2021
Q2 | $9.61M | Buy |
300,207
+10,000
| +3% | +$320K | 0.78% | 14 |
|
|
2021
Q1 | $10.2M | Buy |
+290,207
| New | +$10.2M | 0.34% | 16 |
|
|
2020
Q2 | – | Sell |
-55,172
| Closed | -$1.88M | – | 127 |
|
|
2020
Q1 | $1.88M | Buy |
+55,172
| New | +$1.88M | 0.14% | 38 |
|